DZ BANK/CALL/DERMAPHARM HOLDING/60/0.1/21.06.24 Stock

Warrant

DE000DW3JDB5

Delayed Deutsche Boerse AG 07:35:16 2024-05-21 am EDT
0.001 EUR 0.00% Intraday chart for DZ BANK/CALL/DERMAPHARM HOLDING/60/0.1/21.06.24

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-21 0.001 0.00%
24-05-20 0.001 0.00%
24-05-17 0.001 0.00%
24-05-16 0.001 0.00%
24-05-15 0.001 0.00%

Delayed Quote Deutsche Boerse AG

Last update May 21, 2024 at 07:35 am EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying DERMAPHARM HOLDING SE
Issuer DZ BANK
WKN DW3JDB
ISINDE000DW3JDB5
Date issued 2022-06-22
Strike 60
Maturity 2024-06-21 (31 Days)
Parity 10 : 1
Emission price 0.46
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.12
Lowest since issue 0.001
Delta0.06x
Omega 8.402
Premium66.22x
Gearing142.16x
Moneyness 0.6042
Difference Strike 23.67
Difference Strike %+39.46%
Spread 0.049
Spread %98.00%
Intrinsic value 0.000000

Company Profile

Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Sector
-
More about the company

Ratings for Dermapharm Holding SE

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Dermapharm Holding SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
37.3 EUR
Average target price
56.9 EUR
Spread / Average Target
+52.55%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW